TechCN

X4 Pharmaceuticals to Report Fourth-Quarter and Full-Year

BOSTON, March 07, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small molecule......